Intersect ENT Announces Exercise of Underwriters’ Option and the Closing of Its Public Offering Underwriters Exercise Option for 537,300 Shares of Common Stock, Increasing Total Aggregate Proceeds to Approximately $103 - Prospectus - Document - PDFSEARCH.IO

First Page	Meta Content
	Intersect ENT Announces Exercise of Underwriters’ Option and the Closing of Its Public Offering Underwriters Exercise Option for 537,300 Shares of Common Stock, Increasing Total Aggregate Proceeds to Approximately $103 Add to Reading List Document Date: 2015-06-08 20:11:53 Open Document File Size: 367,06 KB Share Result on Facebook City MENLO PARK / Edgewood / / Company Merrill Lynch / Intersect ENT Inc. / J.P. Morgan Securities LLC / Leerink Partners / J.P. Morgan / Broadridge Financial Solutions / / Country United States / / Currency USD / / / MedicalCondition chronic infections / chronic sinusitis undergoing ethmoid sinus surgery / chronic sinusitis / inflammatory condition leading / / MedicalTreatment sinus surgery / / Organization Prospectus Department / Securities and Exchange Commission / / Person Jeri Hilleman / / / Position Governor / / ProvinceOrState California / New York / / URL www.sec.gov / / SocialTag Corporate finance United States Securities and Exchange Commission Securities Finance Prospectus Registration statement Initial public offering Sinusitis Stock market Financial economics

Intersect ENT Announces Exercise of Underwriters’ Option and the Closing of Its Public Offering Underwriters Exercise Option for 537,300 Shares of Common Stock, Increasing Total Aggregate Proceeds to Approximately $103Add to Reading List